Biohemijski uticaj deksmedetomidina na inflamatorne i stresne markere u hirurgiji raka želuca: meta-analiza: Serum Markers in Dexmedetomidine Anesthesia
Scindeks Asistent Scindeks Asistent — sistem za ozbiljne časopise i one koji to žele da postanu
PDF (engleski)

Sažetak

Background: Dexmedetomidine, an α2-adrenergic agonist, has been reported to modulate inflammatory responses and neuroendocrine stress in surgical settings. This meta-analysis evaluated its effects on serum biochemical markers of inflammation and stress in patients undergoing gastric cancer surgery.

Methods: Literature was retrieved from PubMed, CNKI, Wanfang, and VIP databases. Studies comparing dexmedetomidine anesthesia with conventional regimens in gastric cancer surgery were included. RevMan 5.2 was used for meta-analysis. Outcome indicators included interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), cortisol, epinephrine, adrenocorticotropic hormone (ACTH), heart rate (HR), mean arterial pressure (MAP), and adverse events.

Results: Fifteen studies were analyzed. Compared with controls, dexmedetomidine significantly reduced serum levels of IL-6, TNF-α, cortisol, epinephrine, and ACTH (all P < 0.00001). It also decreased HR, MAP, visual analog scale (VAS) scores, and incidence of adverse reactions.

Conclusion: Dexmedetomidine anesthesia effectively reduces biochemical markers of inflammation and stress in gastric cancer surgery, suggesting its beneficial role in modulating perioperative biochemical responses.

Ključne reči

Array
Array
Array
Array
Array
Array
DOI: 10.5937/jomb0-60059

Reference

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Preuzimanja

Podaci o preuzimanju još nisu dostupni.